129 related articles for article (PubMed ID: 37699241)
1. Examining Associations Between Cannabis Use Disorder and Measures of Weekly and Within-Day Cannabis Frequency, Quantity, and Potency in College Students.
Piercey CJ; Mataczynski M; Stallsmith VT; Emery NN; Karoly HC
Cannabis Cannabinoid Res; 2024 Jun; 9(3):e917-e923. PubMed ID: 37699241
[No Abstract] [Full Text] [Related]
2. Cannabis use in civilian college students and college student service members/veterans: the moderating effect of anxiety.
Teeters JB; Woodward MJ; Meshesha LZ; Tripp JC
Am J Drug Alcohol Abuse; 2020 Nov; 46(6):777-783. PubMed ID: 32469609
[No Abstract] [Full Text] [Related]
3. Predictive validity of cannabis consumption measures: Results from a national longitudinal study.
Buu A; Hu YH; Pampati S; Arterberry BJ; Lin HC
Addict Behav; 2017 Oct; 73():36-40. PubMed ID: 28463803
[TBL] [Abstract][Full Text] [Related]
4. Quantity and frequency of cannabis use in relation to cannabis-use disorder and cannabis-related problems.
Callaghan RC; Sanches M; Kish SJ
Drug Alcohol Depend; 2020 Dec; 217():108271. PubMed ID: 32977043
[TBL] [Abstract][Full Text] [Related]
5. Association Between Recreational Marijuana Legalization in the United States and Changes in Marijuana Use and Cannabis Use Disorder From 2008 to 2016.
Cerdá M; Mauro C; Hamilton A; Levy NS; Santaella-Tenorio J; Hasin D; Wall MM; Keyes KM; Martins SS
JAMA Psychiatry; 2020 Feb; 77(2):165-171. PubMed ID: 31722000
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and associated factors of cannabis consumption in medical students: the BOURBON nationwide study.
Fond G; Picot A; Bourbon A; Boucekine M; Auquier P; Lançon C; Boyer L
Eur Arch Psychiatry Clin Neurosci; 2021 Aug; 271(5):857-864. PubMed ID: 32372364
[TBL] [Abstract][Full Text] [Related]
7. Differences in internalizing symptoms between those with and without Cannabis Use Disorder among HBCU undergraduate students.
Keen L; Turner AD; Harris T; George L; Crump J
J Am Coll Health; 2023 Nov; 71(8):2390-2397. PubMed ID: 36108170
[TBL] [Abstract][Full Text] [Related]
8. Higher average potency across the United States is associated with progression to first cannabis use disorder symptom.
Arterberry BJ; Treloar Padovano H; Foster KT; Zucker RA; Hicks BM
Drug Alcohol Depend; 2019 Feb; 195():186-192. PubMed ID: 30573162
[TBL] [Abstract][Full Text] [Related]
9. The social context of cannabis use: relationship to cannabis use disorders and depressive symptoms among college students.
Beck KH; Caldeira KM; Vincent KB; O'Grady KE; Wish ED; Arria AM
Addict Behav; 2009 Sep; 34(9):764-8. PubMed ID: 19497678
[TBL] [Abstract][Full Text] [Related]
10. Post-traumatic stress and marijuana outcomes: The mediating role of marijuana protective behavioral strategies.
Jordan HR; Madson MB; Bravo AJ; Pearson MR;
Subst Abus; 2020; 41(3):375-381. PubMed ID: 31361581
[No Abstract] [Full Text] [Related]
11. Associations of cannabis use, use frequency, and cannabis use disorder with violent behavior among young adults in the United States.
Volkow ND; Compton WM; Blanco C; Einstein EB; Han B
Int J Drug Policy; 2024 Jun; 128():104431. PubMed ID: 38677161
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States.
Wu LT; Zhu H; Mannelli P; Swartz MS
Drug Alcohol Depend; 2017 Aug; 177():153-162. PubMed ID: 28599214
[TBL] [Abstract][Full Text] [Related]
13. Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults.
Leadbeater BJ; Ames ME; Linden-Carmichael AN
Addiction; 2019 Feb; 114(2):278-293. PubMed ID: 30276906
[TBL] [Abstract][Full Text] [Related]
14. Cannabis use and its association with psychopathological symptoms in a Swiss adult population: a cross-sectional analysis.
Mosandl CF; Baltes-Flückiger L; Kronschnabel J; Meyer M; Guessoum A; Herrmann O; Vogel M; Walter M; Pichler EM
Front Public Health; 2024; 12():1356988. PubMed ID: 38841675
[TBL] [Abstract][Full Text] [Related]
15. Psychosocial functioning among regular cannabis users with and without cannabis use disorder.
Foster KT; Arterberry BJ; Iacono WG; McGue M; Hicks BM
Psychol Med; 2018 Aug; 48(11):1853-1861. PubMed ID: 29173210
[TBL] [Abstract][Full Text] [Related]
16. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.
Tomko RL; Baker NL; Hood CO; Gilmore AK; McClure EA; Squeglia LM; McRae-Clark AL; Sonne SC; Gray KM
Psychopharmacology (Berl); 2020 Feb; 237(2):479-490. PubMed ID: 31712969
[TBL] [Abstract][Full Text] [Related]
17. Cannabis Use Disorder Symptoms in Weekly Cannabis Users: A Network Comparison Between Daily Cigarette Users and Nondaily Cigarette Users.
Freichel R; Kroon E; Kuhns L; Filbey F; Veer IM; Wiers R; Cousijn J
Cannabis Cannabinoid Res; 2024 Jun; 9(3):e847-e858. PubMed ID: 37074121
[No Abstract] [Full Text] [Related]
18. Self-reported symptoms of cannabis use disorder: Psychometric testing and validation.
Richards DK; Schwebel FJ; Sotelo M; Pearson MR;
Exp Clin Psychopharmacol; 2021 Apr; 29(2):157-165. PubMed ID: 34043399
[TBL] [Abstract][Full Text] [Related]
19. Cannabis use disorders among adults in the United States during a time of increasing use of cannabis.
Compton WM; Han B; Jones CM; Blanco C
Drug Alcohol Depend; 2019 Nov; 204():107468. PubMed ID: 31586809
[TBL] [Abstract][Full Text] [Related]
20. The occurrence of cannabis use disorders and other cannabis-related problems among first-year college students.
Caldeira KM; Arria AM; O'Grady KE; Vincent KB; Wish ED
Addict Behav; 2008 Mar; 33(3):397-411. PubMed ID: 18031940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
